AI in Oncology Market

The AI in oncology market applies artificial intelligence to various stages of cancer management, including detection, screening, diagnosis, treatment, and drug discovery. Key customers include healthcare organizations, research institutions, and pharmaceutical companies. The market's growth is primarily driven by the rising global incidence of cancer, significant advancements in AI technologies like deep learning, and a surge in public and private investment in R&D.

CAGR

29.7%

Compound Annual Growth Rate

Current Value

$2.05B

Estimated 2026

Projected Value

$16.4B

By 2034